Cargando…
骨髓增生异常综合征患者去甲基化治疗后WT1 mRNA水平的变化及其预后意义
OBJECTIVE: To monitor the WT1 mRNA level and its dynamic changes in patients with myelodysplastic syndromes (MDS) after hypomethylating agents (HMA), as well as to assess the significance of WT1 mRNA levels and its dynamic changes in evaluating the efficacy of HMA and distinguishing the disease stat...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342245/ https://www.ncbi.nlm.nih.gov/pubmed/31207708 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.05.013 |